Humacyte Inc.

NASDAQ: HUMAW · Real-Time Price · USD
0.49
-0.03 (-5.50%)
At close: Aug 01, 2025, 3:43 PM

Humacyte Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-148.7M -110.78M -11.96M -26.48M
Depreciation & Amortization
7.19M 7.72M 8.21M 8.24M
Stock-Based Compensation
6.14M 6.83M 6.18M 10.15M
Other Working Capital
2.27M 1.73M 1.39M -116K
Other Non-Cash Items
36.94M 16.35M -74.41M -54.74M
Deferred Income Tax
n/a n/a -173K -17.8M
Change in Working Capital
311K 6.57M 1.03M -557K
Operating Cash Flow
-98.12M -73.31M -71.13M -81.19M
Capital Expenditures
-1.57M -2.28M -1.05M -220K
Cash Acquisitions
n/a n/a -5.89M n/a
Purchase of Investments
n/a n/a -10.11M -8M
Sales Maturities Of Investments
n/a 2.11M 16M n/a
Other Investing Acitivies
n/a n/a 5.89M -8M
Investing Cash Flow
-1.57M -173K 4.84M -8.22M
Debt Repayment
-2.58M -34.07M -1.98M 27.93M
Common Stock Repurchased
708K n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
27.71M 38.57M 535K 239.05M
Financial Cash Flow
114.18M 4.51M -1.45M 266.98M
Net Cash Flow
14.49M -68.97M -67.73M 177.57M
Free Cash Flow
-99.69M -75.58M -72.18M -81.41M